Financial reports
10-Q
2024 Q2
Quarterly report
5 Aug 24
10-Q
2024 Q1
Quarterly report
3 May 24
ARS
2023 FY
Annual report to shareholders
5 Apr 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
ARS
2022 FY
Annual report to shareholders
6 Apr 23
10-K
2022 FY
Annual report
24 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
Current reports
8-K
Material Modifications to Rights of Security Holders
30 Jul 24
8-K
Morgan Stanley Second Quarter 2024 Earnings Results
16 Jul 24
8-K
Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity Share Repurchase Program
28 Jun 24
8-K
Departure of Directors or Certain Officers
24 May 24
8-K
Morgan Stanley First Quarter 2024 Earnings Results
16 Apr 24
8-K
Departure of Directors or Certain Officers
19 Jan 24
8-K
Morgan Stanley Fourth Quarter and Full Year 2023 Earnings Results
16 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
8 Dec 23
8-K
Departure of Directors or Certain Officers
1 Dec 23
8-K
Departure of Directors or Certain Officers
27 Oct 23
Registration and prospectus
424B2
Prospectus for primary offering
9 Oct 24
424B2
Prospectus for primary offering
9 Oct 24
424B2
Prospectus for primary offering
9 Oct 24
424B2
Prospectus for primary offering
9 Oct 24
424B2
Prospectus for primary offering
9 Oct 24
424B2
Prospectus for primary offering
9 Oct 24
424B2
Prospectus for primary offering
9 Oct 24
424B2
Prospectus for primary offering
9 Oct 24
424B2
Prospectus for primary offering
9 Oct 24
424B2
Prospectus for primary offering
9 Oct 24
Proxies
N-PX
Annual report of proxy voting record
28 Aug 24
DEFA14A
Additional proxy soliciting materials
9 May 24
PX14A6G
Letter to shareholders
10 Apr 24
PX14A6G
Letter to shareholders
8 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
PX14A6G
Letter to shareholders
25 Mar 24
PX14A6G
Letter to shareholders
21 Mar 24
PX14A6G
Letter to shareholders
14 Apr 23
Other
CERT
Certification of approval for exchange listing
30 Jul 24
EFFECT
Notice of effectiveness
15 Apr 24
CERT
Certification of approval for exchange listing
3 Aug 22
CERT
Certification of approval for exchange listing
25 Jul 22
CERT
Certification of approval for exchange listing
26 Oct 21
EFFECT
Notice of effectiveness
1 Feb 21
CORRESP
Correspondence with SEC
26 Jan 21
CORRESP
Correspondence with SEC
19 Jan 21
UPLOAD
Letter from SEC
21 Dec 20
EFFECT
Notice of effectiveness
15 Jun 20
Ownership
SC 13G/A
CEDAR FAIR L P
7 Oct 24
SC 13G/A
Replimune Group, Inc.
7 Oct 24
SC 13G/A
Apollo Senior Floating Rate Fund Inc.
7 Oct 24
SC 13G/A
Celcuity Inc.
7 Oct 24
SC 13G/A
Virtus Convertible & Income 2024 Target Term Fund
7 Oct 24
SC 13G/A
Global Ship Lease, Inc.
10 Sep 24
SC 13G/A
BlackRock 2037 Municipal Target Term Trust
10 Sep 24
SC 13G/A
Dolby Laboratories, Inc.
10 Sep 24
SC 13G/A
NETSTREIT Corp.
9 Sep 24
SC 13G/A
Outset Medical, Inc.
9 Sep 24